Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07226739 · ClinicalTrials.gov registry record · Phase 4
Comprehensive Toileting Program
A Phase 4 study, sponsored by Emory University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 150
- Enrollment target
NCT07226739 is a Phase 4 study that is actively recruiting participants, run by Emory University. The registered enrollment target is 150 participants.
The verdict
NCT07226739, a Phase 4 study, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 150 participants
- Enrollment target
Study Summary
The current study aims to monitor fecal continence after autistic youth complete enuresis treatment and for individuals who continue to experience encopresis after acquiring urine continence, evaluate a caregiver-mediated version of a Multidisciplinary Intervention for Encopresis (CM-MIE) delivered via telehealth to determine efficacy in a randomized clinical trial.
Interventions
- DRUG Glycerin Suppository
- BEHAVIORAL Behavioral strategies
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2031-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07226739
The ClinicalTrials.gov registry entry for NCT07226739 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Glycerin Suppository is the first listed.
NCT07226739 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07226739 about?
NCT07226739 is a clinical study titled "Comprehensive Toileting Program". The current study aims to monitor fecal continence after autistic youth complete enuresis treatment and for individuals who continue to experience encopresis after acquiring urine continence, evaluate a caregiver-mediated version of a Multidisciplinary Intervention for Encopresis (CM-MIE) delivered ...
What is the current status of trial NCT07226739?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2026-06-01. Estimated completion is 2031-01.
What interventions are being tested in trial NCT07226739?
The interventions under investigation include: Glycerin Suppository (DRUG), Behavioral strategies (BEHAVIORAL).
Who is sponsoring clinical trial NCT07226739?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.